# Research Study for Major Depressive Disorder: Investigation of Glutamate Medications

> **NCT00419003** · PHASE4 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 26 (actual)

## Conditions studied

- Major Depression

## Interventions

- **DRUG:** Lamotrigine
- **DRUG:** Ketamine
- **DRUG:** Riluzole

## Key facts

- **NCT ID:** NCT00419003
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-07
- **Final completion:** 2008-09
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2019-07-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00419003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00419003, "Research Study for Major Depressive Disorder: Investigation of Glutamate Medications". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00419003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*